Drug utilisation study of Eliglustat for the treatment of Gaucher Disease Type 1 in Europe using electronic healthcare records (ELIGLC06913) First published 14/04/2020 Last updated 07/05/2025 EU PAS number:EUPAS34611 Study Finalised
Parexel International United States First published:19/10/2010 Last updated 10/12/2024 Institution Non-Pharmaceutical company ENCePP partner
International Prevention Research Institute (IPRI) France First published:19/03/2010 Last updated 05/04/2012 Institution Outdated EU Institution/Body/Agency ENCePP partner